Friday, December 05, 2025 | 04:04 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Centre, ICMR in talks with Serum Institute of India over Nipah antibody

India may not immediately import Australian drug

Nipah virus
premium

Nipah virus

Shine JacobSohini Das Chennai/Mumbai

Listen to This Article

India may not immediately import an antibody from Australia to combat the Nipah virus as the affected patients in Kerala are out of danger. However, the government and the Indian Council of Medical Research (ICMR) are in talks with the Serum Institute of India (SII) for local manufacturing. Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies (MABs) — that are used on compassionate grounds — for treating Nipah virus infections.

Serum Institute of India, the world’s biggest vaccine maker, did not comment on the development.

Kerala Health Minister Veena George